Rebecca Carroll

A prospective audit on the use of prophylactic antiemetics and rates of CINV in patients receiving carboplatin AUC≥4 or combination anthracycline-cyclophosphamide.

R. Isaacs, G. Forgeson, L. Satterthwaite, 2021, The New Zealand medical journal.